Online Enquiry
Subscribe
Log in / New User
Retrieve Password
此页面上的内容需要较新版本的 Adobe Flash Player。
切换导航
Home
Pharma China Web Edition
Pharma China Archives
Online Databases
Subscription/Download
Event Calendar
China Pharma Providers
About Us
Location:
Home
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Feature articles
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
News in Focus
Editor's Picks
Full Text
Title
Subscribe to Pharma China
Online Enquiry
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
News in Focus
Editor's Picks
ONLINE ENQUIRY
WiCON International Group
Bellevue, WA 98007, USA
info@pharmachinaonline.com
WiCON International Co. Ltd.
Osaka, Japan
info@pharmachinaonline.com
Relate News
1/13/2025
Gentize Biopharma Secures ~CNY 100M in Pre-A Financing to Advance Vacc...
1/12/2025
Moderna Navigates Cautious Expansion Into China Amid Geopolitical Tens...
1/11/2025
Merck's Gardasil 4 Receives New Indication Approval for Males in China
12/16/2024
Sinopharm's Mpox Vaccine Gains Clinical Trial Approval in China
11/1/2024
Merck Faces Gardasil Sales Challenges in China, Impact Expected to Con...
10/29/2024
Clover Announces Positive Results for RSV Vaccine SCB-1019 vs GSK's AR...
10/25/2024
China Expands Free HPV Vaccination to Reach 40% of Eligible Girls
10/24/2024
Sinopharm and Chinese Vaccine Makers Slash Prices Amid Fierce Market C...
10/21/2024
Changing Chinese Market Dynamics Hit Merck Where It Hurts (SCRIP Citel...
10/11/2024
CanSino Receives Over $17M from Gates Foundation to Accelerate Polio V...
9/26/2024
CDE Issues the Technical Guidelines for Vaccine Immunogenicity Bridgin...
9/3/2024
CDE Solicits Comments on Draft of the Technical Guidelines for Vaccine...
8/29/2024
CDE Solicits Comments on Draft of the Technical Guidelines for Non-Cli...
8/28/2024
CDE Solicits Comments on the Technical Guidelines for Non-Clinical Eff...
8/28/2024
CDE Solicits Comments on the Technical Guidelines for Clinical Trials ...
8/27/2024
Sanofi Suspends Supply and Sale of Flu Vaccine in China
8/26/2024
CDE Solicits Public Comments on the Technical Guidelines for Pharmaceu...
8/26/2024
Chinese Pharma Cos Set Sights on Dominating Therapeutic Cancer Vaccine...
8/22/2024
Everest Medicines Announces Initiation of Clinical Trial for Personali...
8/14/2024
GSK Launches Phase 3 Trial for RSV Vaccine in China
8/8/2024
WestGene Secures Dual IND Approvals for mRNA Cancer Vaccine Targeting ...
8/7/2024
Uncertainty Looms Over Gardasil's Future in China
7/25/2024
CDE Solicits Public Comments on the Technical Guidelines for Quality C...
7/25/2024
Innorna Receives IND Clearance for IN001 Herpes Zoster mRNA Vaccine in...
7/15/2024
Domestic Developers File for China's First Home-Made Quadrivalent HPV ...
7/12/2024
NMPA Clears CSPC's RSV Vaccine Candidate for Human Clinical Trials
7/11/2024
Recent Advancements and Challenges in Cervical Cancer Prevention in Ch...
6/28/2024
Walvax and Abogen Terminate Collaboration on mRNA Vaccine Development
6/7/2024
InDevR and Sino Biological Partner to Deliver Multiplexed Solutions fo...
5/28/2024
NMPA Holds Meeting to Review Vaccine Regulatory QMS
Page:
2
/
22
Total number of articles:
654
:
[First]
[<<]
[1]
[2]
[3]
[4]
[5]
[>>]
[End]
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
FEATURE ARTICLES
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
News in Focus
Editor's Picks
GENERAL INFORMATION
TERMS & CONDITIONS OF USE
Download Info
Contact Us
Site map
|
Contact Us
|
Links
© Wicon International Group
×
Join the mailing list
We will e-mail you the most critical news and developments about China's healthcare sector, in real time and absolutely free.
name:
e-mail:
company:
submit